Business
Ventripoint to Exhibit at the 58th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
(TheNewswire) Toronto, Ontario – TheNewswire – May 28, 2025 - Ventripoint Dia...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint to Exhibit at the 58th Annual Meeting of the Association for European Paediatric and Congenital Cardiology\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Toronto, Ontario – TheNewswire – May 28, 2025 -\nVentripoint Diagnostics Ltd. (\"Ventripoint\" or the\n\"Company\"), (TSXV:VPT; OTC:VPTDF) is pleased to announce its\nparticipation in the 58th Annual Meeting of the Association for\nEuropean Paediatric and Congenital Cardiology (AEPC) being held on May\n28th-31st 2025 in Hamburg, Germany.\n \n\n\n\n The AEPC is a network of specialists committed to the\npractice and advancement of Congential Cardiology and closely related\nfields. Since its founding in 1963 AEPC has grown to become the\nlargest global association in congenital cardiology with over 1,000\nmembers. We are excited to be part of this international community and\nto work with its members to enhance cardiac care.\n \n\n\n\n This year’s meeting is hosted by the local organising\ncommittee from the University Heart & Vascular Center Hamburg,\nChildren’s Heart Medicine and Adults with Congenital Heart Disease.\nVentripoint is exhibiting at the meeting and we look forward to seeing\nour customers, connecting with  clinicians within the international\ncongenital cardiology community and continuing to expand our global\nnetwork.\n \n\n\n\n Our focus for this year is on growing our customer base\nand working with clinicians to expand the use of VMS+ in routine\nclinical workflow. The advancements provided in VMS+ versions 3.2 and\n4.0 during the past year were designed to provide improved\nproduct-user fit and better integration into clinical workflow.  VMS+\nenables a more efficient patient journey by providing information\nabout the structure and function of the heart with accuracy equivalent\nto cardiac MRI at the time of the patient’s first echo scan. This\ndetailed information, generated early in the care journey, leads to\nimproved quality of diagnosis, potentially shortening time to therapy,\nand increased efficacy of patient management and care throughout the\npatient’s life.\n \n\n\n\n “We value the opportunity to support AEPC, its\nmembers within 32 European countries and their peers from other\ncontinents” said Ventripoint Pre...